This book functions as a clinician’s guide to the use of cannabidiol (CBD) in the treatment of mental health conditions. It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use.The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies.
Unique and focused,
Medicinal Cannabis and CBD in Mental Healthcare
is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.
O'Brien / Blair
Medicinal Cannabis and CBD in Mental Healthcare jetzt bestellen!
Zielgruppe
Professional/practitioner
Weitere Infos & Material
Introduction.- Endocannabinoid system.- ECS and regulation of stress.- Overview of cannabis.- Stress and Anxiety.-Depression.- PSTD.- Sleep.- Alzheimers.- Autism.- Conclusion.
Professor Kylie O’Brien PhD
Kylie O’Brien PhDAdjunct Professor Torrens UniversityDirector of Research & Education
International College of Cannabinoid Medicine
Email: kylie@iccm.co
Phone: +61 412 077689
Dr Philip Blair, MD
Dr. Philip Blair, MD, Colonel (US Army Ret)CEO of AbleDoc, Inc, International Medical ConsultantChief Medical Officer, International College of Cannabinoid MedicineChief Medical Officer, Releaf Clinics, AustraliaChief Science Officer for Harvest 360
Castle Rock, Washington
email: abledoc@mac.com